1458019

Neomycin B

United States Pharmacopeia (USP) Reference Standard

• Synonyme(s) : (2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-b-L-idopyranosyl)-b-D-ribofuranosyl]-D-streptamine sulfate)
• Formule empirique (notation de Hill) : C₂₃H₄₆N₆O₁₃ · xH₂SO₄
• Numéro CAS: 28002-70-2
• Poids moléculaire : 614.64 (free base basis)
• MDL number: MFCD00037007
• UNSPSC Code: 41116107
• NACRES: NA.24

Propriétés

• grade: pharmaceutical primary standard
• agency: USP
• API family: neomycin
• form: solid
• packaging: pkg of 150 mg
• manufacturer/tradename: USP
• application(s): USP Biologics; pharmaceutical
• format: neat
• storage temp.: −20°C
• SMILES string: [S](=O)(=O)(O)O.N[C@H]1[C@H](O[C@H]([C@H]([C@@H]1O)O)CN)O[C@@H]2[C@H](O[C@H]([C@@H]2O)O[C@H]3[C@@H]([C@H](C[C@H]([C@@H]3O)N)N)O[C@H]4O[C@@H]([C@H]([C@@H]([C@H]4N)O)O)CN)CO
• InChI: 1S/C23H46N6O13.H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;/m1./s1
• InChI key: OIXVKQDWLFHVGR-WQDIDPJDSA-N

Description

General description

Neomycin B is one of the major components of neomycin sulfate, an aminoglycoside antibiotic produced by Streptomyces fradiae. It exerts bactericidal effects by binding to the 30S ribosomal subunit, leading to inhibition of protein synthesis and misreading of mRNA. The USP standard supports identification and quantification of this individual neomycin component in complex mixtures.The USP biologics antibiotics category includes a wide range of antimicrobial agents that are essential in treating bacterial infections. These antibiotics are derived from various natural sources or synthesized to combat specific pathogens effectively. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of antibiotic therapeutics throughout their lifecycle.The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.
Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Neomycin B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Neomycin Sulfate

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Other Notes

Sales restrictions may apply.

This product is part of the USP Biologics program.

USP issued SDS can be found here.

Informations sur la sécurité

• Pictogrammes: GHS07
• Mot-clé: Warning
• Codes de danger: H317
• Mentions de précaution: P261 - P272 - P280 - P302 + P352 - P333 + P313 - P362 + P364
• Hazard Classifications: Skin Sens. 1
• Classe de stockage: 13 - Non Combustible Solids
• Que se passe-t-il ?: WGK 3
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable